Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research
Funds early proof-of-concept work testing whether a new cancer research tool, assay, platform or instrument is technically feasible at all.
A brand-new way to measure, image or analyse cancer usually starts as an idea nobody has proven works yet. Before it can go anywhere — before a lab adopts it, before a bigger validation study gets funded — someone has to test whether it is technically feasible at all.
That is what this funds: early-stage, proof-of-concept and pilot studies testing the feasibility of a new method, tool, assay, pla…
Early-stage, proof-of-concept and pilot studies testing the technical feasibility of a new method, tool, assay, platform or instrument for cancer research or clinical care — including molecular and cellular analysis platforms, multi-omic and spatial profiling, imaging and sensing technologies, immuno-engineering, and biospecimen processing — judged on technical innovation rather than disease focus.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up